Concordia International (CXR) Hits New 1-Year High at $25.01
Concordia International Corp (TSE:CXR) (NASDAQ:CXRX)’s share price reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as C$25.01 and last traded at C$25.00, with a volume of 38704 shares changing hands. The stock had previously closed at C$0.16.
Separately, Bloom Burton restated a “hold” rating on shares of Concordia International in a report on Tuesday.
Concordia International Company Profile (TSE:CXR)
Concordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies.
Receive News & Ratings for Concordia International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia International and related companies with MarketBeat.com's FREE daily email newsletter.